Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Clinical trial NCT04212169 · COMPLETED

Trial details

NCT number: NCT04212169
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2019-12-09
Primary completion: 2022-07-21
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.